<!doctype html>
<html lang="de-DE">
  <head>
    <meta charset="utf-8" />
    <meta name="viewport" content="width=device-width,initial-scale=1" />
    <meta name="generator" content="VuePress 2.0.0-rc.20" />
    <style>
      :root {
        --vp-c-bg: #fff;
      }

      [data-theme='dark'] {
        --vp-c-bg: #1b1b1f;
      }

      html,
      body {
        background-color: var(--vp-c-bg);
      }
    </style>
    <script>
      const useChoice = localStorage.getItem('vuepress-color-scheme')
      const systemStatus =
        'matchMedia' in window
          ? window.matchMedia('(prefers-color-scheme: dark)').matches
          : false

      if (useChoice === 'light') {
        document.documentElement.dataset.theme = 'light'
      } else if (useChoice === 'dark' || systemStatus) {
        document.documentElement.dataset.theme = 'dark'
      }
    </script>
    <title>EpiSim - Simulation | Covid Sim Doku</title><meta name="description" content="Dokumentation zum Covid Simulator">
    <link rel="preload" href="/assets/style-DD-zM4WE.css" as="style"><link rel="stylesheet" href="/assets/style-DD-zM4WE.css">
    <link rel="modulepreload" href="/assets/app-BI-xpNOO.js"><link rel="modulepreload" href="/assets/episimsimulation.html-DyR0IOX6.js">
    <link rel="prefetch" href="/assets/index.html-CboldOYP.js" as="script"><link rel="prefetch" href="/assets/index.html-DVAVR2ud.js" as="script"><link rel="prefetch" href="/assets/configuration.html-xtr9aW0t.js" as="script"><link rel="prefetch" href="/assets/example.html-W8fqYrSo.js" as="script"><link rel="prefetch" href="/assets/introduction.html-Eyec3Qsv.js" as="script"><link rel="prefetch" href="/assets/outputandanalysis.html-at_o6lnO.js" as="script"><link rel="prefetch" href="/assets/plots.html-R0YrMhkp.js" as="script"><link rel="prefetch" href="/assets/quickstart.html-BQtrbIIy.js" as="script"><link rel="prefetch" href="/assets/repositorystructure.html-C0aTBnV0.js" as="script"><link rel="prefetch" href="/assets/run-setup.html-mfY7o3cJ.js" as="script"><link rel="prefetch" href="/assets/simulationsetup.html-DfsufGMx.js" as="script"><link rel="prefetch" href="/assets/website.html-vlTlUkfM.js" as="script"><link rel="prefetch" href="/assets/404.html-D7gBicfV.js" as="script">
  </head>
  <body>
    <div id="app"><!--[--><div class="vp-theme-container external-link-icon" vp-container><!--[--><header class="vp-navbar" vp-navbar><div class="vp-toggle-sidebar-button" title="toggle sidebar" aria-expanded="false" role="button" tabindex="0"><div class="icon" aria-hidden="true"><span></span><span></span><span></span></div></div><span><a class="route-link" href="/"><!----><span class="vp-site-name" aria-hidden="true">Covid Sim Doku</span></a></span><div class="vp-navbar-items-wrapper" style=""><!--[--><!--]--><nav class="vp-navbar-items vp-hide-mobile" aria-label="site navigation"><!--[--><div class="vp-navbar-item"><a class="route-link route-link-active auto-link" href="/docs2/" aria-label="Dokumentation"><!--[--><!--[--><!--]--><!--]-->Dokumentation<!--[--><!--[--><!--]--><!--]--></a></div><!--]--></nav><!--[--><!--]--><button type="button" class="vp-toggle-color-mode-button" title="toggle color mode"><svg class="light-icon" viewbox="0 0 32 32" style=""><path d="M16 12.005a4 4 0 1 1-4 4a4.005 4.005 0 0 1 4-4m0-2a6 6 0 1 0 6 6a6 6 0 0 0-6-6z" fill="currentColor"></path><path d="M5.394 6.813l1.414-1.415l3.506 3.506L8.9 10.318z" fill="currentColor"></path><path d="M2 15.005h5v2H2z" fill="currentColor"></path><path d="M5.394 25.197L8.9 21.691l1.414 1.415l-3.506 3.505z" fill="currentColor"></path><path d="M15 25.005h2v5h-2z" fill="currentColor"></path><path d="M21.687 23.106l1.414-1.415l3.506 3.506l-1.414 1.414z" fill="currentColor"></path><path d="M25 15.005h5v2h-5z" fill="currentColor"></path><path d="M21.687 8.904l3.506-3.506l1.414 1.415l-3.506 3.505z" fill="currentColor"></path><path d="M15 2.005h2v5h-2z" fill="currentColor"></path></svg><svg class="dark-icon" viewbox="0 0 32 32" style="display:none;"><path d="M13.502 5.414a15.075 15.075 0 0 0 11.594 18.194a11.113 11.113 0 0 1-7.975 3.39c-.138 0-.278.005-.418 0a11.094 11.094 0 0 1-3.2-21.584M14.98 3a1.002 1.002 0 0 0-.175.016a13.096 13.096 0 0 0 1.825 25.981c.164.006.328 0 .49 0a13.072 13.072 0 0 0 10.703-5.555a1.01 1.01 0 0 0-.783-1.565A13.08 13.08 0 0 1 15.89 4.38A1.015 1.015 0 0 0 14.98 3z" fill="currentColor"></path></svg></button><form class="search-box" role="search"><input type="search" placeholder="Suche..." autocomplete="off" spellcheck="false" value><!----></form></div></header><!--]--><div class="vp-sidebar-mask"></div><!--[--><aside class="vp-sidebar" vp-sidebar><nav class="vp-navbar-items" aria-label="site navigation"><!--[--><div class="vp-navbar-item"><a class="route-link route-link-active auto-link" href="/docs2/" aria-label="Dokumentation"><!--[--><!--[--><!--]--><!--]-->Dokumentation<!--[--><!--[--><!--]--><!--]--></a></div><!--]--></nav><!--[--><!--]--><ul class="vp-sidebar-items"><!--[--><li><p tabindex="0" class="vp-sidebar-item vp-sidebar-heading active">Dokumentation <!----></p><ul style="" class="vp-sidebar-children"><!--[--><li><a class="route-link route-link-active auto-link vp-sidebar-item" href="/docs2/" aria-label="Introduction"><!--[--><!--[--><!--]--><!--]-->Introduction<!--[--><!--[--><!--]--><!--]--></a><!----></li><li><a class="route-link auto-link vp-sidebar-item" href="/docs2/run-setup.html" aria-label="MATSim Episim"><!--[--><!--[--><!--]--><!--]-->MATSim Episim<!--[--><!--[--><!--]--><!--]--></a><!----></li><li><a class="route-link auto-link vp-sidebar-item" href="/docs2/configuration.html" aria-label="Configuration"><!--[--><!--[--><!--]--><!--]-->Configuration<!--[--><!--[--><!--]--><!--]--></a><!----></li><li><a class="route-link auto-link vp-sidebar-item" href="/docs2/website.html" aria-label="COVID Episim Website"><!--[--><!--[--><!--]--><!--]-->COVID Episim Website<!--[--><!--[--><!--]--><!--]--></a><!----></li><li><a class="route-link auto-link vp-sidebar-item" href="/docs2/plots.html" aria-label="Plots"><!--[--><!--[--><!--]--><!--]-->Plots<!--[--><!--[--><!--]--><!--]--></a><!----></li><li><a class="route-link auto-link vp-sidebar-item" href="/docs2/introduction.html" aria-label="EpiSim - Introduction"><!--[--><!--[--><!--]--><!--]-->EpiSim - Introduction<!--[--><!--[--><!--]--><!--]--></a><!----></li><li><a class="route-link auto-link vp-sidebar-item" href="/docs2/quickstart.html" aria-label="EpiSim - Quickstart"><!--[--><!--[--><!--]--><!--]-->EpiSim - Quickstart<!--[--><!--[--><!--]--><!--]--></a><!----></li><li><a class="route-link auto-link vp-sidebar-item" href="/docs2/repositorystructure.html" aria-label="EpiSim - Repository Structure"><!--[--><!--[--><!--]--><!--]-->EpiSim - Repository Structure<!--[--><!--[--><!--]--><!--]--></a><!----></li><li><a class="route-link auto-link vp-sidebar-item" href="/docs2/simulationsetup.html" aria-label="EpiSim - Simulation Setup"><!--[--><!--[--><!--]--><!--]-->EpiSim - Simulation Setup<!--[--><!--[--><!--]--><!--]--></a><!----></li><li><a class="route-link route-link-active auto-link vp-sidebar-item active" href="/docs2/episimsimulation.html" aria-label="EpiSim - Simulation"><!--[--><!--[--><!--]--><!--]-->EpiSim - Simulation<!--[--><!--[--><!--]--><!--]--></a><!----></li><li><a class="route-link auto-link vp-sidebar-item" href="/docs2/outputandanalysis.html" aria-label="EpiSim - Outputs and Analysis"><!--[--><!--[--><!--]--><!--]-->EpiSim - Outputs and Analysis<!--[--><!--[--><!--]--><!--]--></a><!----></li><!--]--></ul></li><!--]--></ul><!--[--><!--]--></aside><!--]--><!--[--><main class="vp-page"><!--[--><!--]--><div vp-content><!--[--><!--]--><div><h1 id="episim-simulation" tabindex="-1"><a class="header-anchor" href="#episim-simulation"><span>EpiSim - Simulation</span></a></h1><p>So far, the scenario preparation process has been described; the episim-config data structure, the various inputs, and the restriction policies have been detailed. Now, it is time for the simulation to begin. At the beginning of the simulation, a random set of individuals is infected. The class <code>EpisimRunner</code> iterates through all the days (iterations) in the simulation. As previously mentioned, in the VSP case, one simulated week involves replaying the weekday events five times, followed by the Saturday events and, finally, the Sunday events.</p><p>At the beginning of each day, there is a certain initialization phase: e.g. vaccinations and tests are administered to portions of the population. This is also where the disease progression model changes the disease states of individuals (see <em><a href="#disease-progression-model">Disease Progression Model</a></em>). Based on transition probabilities, some infectious individuals start, for example, to show symptoms or some seriously sick individuals recover.</p><p>At the beginning of a day, the <code>DefaultParticipationModel</code> ascertains which activities should be skipped. Since the events file corresponds to pre-coronavirus activity trajectories, a certain portion of planned daily activities should be removed due to pandemic-induced mobility reductions. For each event in the day&#39;s events file, the applicable <code>remainingFraction</code> is extracted from the <code>Restriction</code> for the activity type and date in question. A random number between 0.0 and 1.0 is then generated; if it lies above the <code>remainingFraction</code>, then the activity will not occur on this day. Thus, for a <code>remainingFraction</code> of 66% at work, approximately one-third of all work activities for that day will not occur. If an activity is skipped, then the associated public transit travel to (and from) that activity will also not be realized.</p><p>Each day is simulated as follows: the corresponding events file is replayed minute-by-minute, by processing the events chronologically. EpiSim predicts daily infection dynamics using three interlocking sub-models: the contact model identifies situations where agents meet; given an agent is infectious, the infection model predicts whether SARS-CoV-2 is transmitted to a susceptible agent; if an agent is infected, the disease progression model determines the course and severity of the disease (<a href="https://doi.org/10.48550/arXiv.2011.11453" target="_blank" rel="noopener noreferrer">Müller 2020</a>). Following, these three core models will be introduced, as well as two optional submodels: the vaccination and antibody models.</p><h2 id="contact-model" tabindex="-1"><a class="header-anchor" href="#contact-model"><span>Contact Model</span></a></h2><p>The <code>DefaultContactModel</code> starts the day with a set of empty containers, corresponding to all the enclosed spaces where agents can meet (activity facilities and public transit vehicles). The <code>ReplayHandler</code> class then replays all the events that occur in a day in chronological order.</p><p>If an activity occurs (as specified by the <code>DefaultParticipationModel</code>), the <code>DefaultContactModel</code> will then add the agent in question to the corresponding container. When the events file specifies that an agent ends an activity, the <code>DefaultContactModel</code> checks whether at least one person in the container is susceptible and one is infectious. If so, this agent-pair is passed along to the <code>InfectionEventHandler</code>, which will check whether an infection actually occurs. This same process also occurs when an agents enters or leaves a public transit vehicle (<a href="https://doi.org/10.48550/arXiv.2011.11453" target="_blank" rel="noopener noreferrer">Müller 2020</a>).</p><h2 id="infection-model" tabindex="-1"><a class="header-anchor" href="#infection-model"><span>Infection Model</span></a></h2><p>If the contact model renders that a contagious person met with a susceptible person, then the infection model calculates the probability that an infection occurs. EpiSim uses a mechanical infection model ( <a href="https://doi.org/10.1186/1742-4682-6-25" target="_blank" rel="noopener noreferrer">Smieszek 2009</a>, <a href="https://doi.org/10.1186/1471-2334-11-115" target="_blank" rel="noopener noreferrer">Smieszek 2011</a>)<sup class="footnote-ref"><a href="#footnote1">[1]</a><a class="footnote-anchor" id="footnote-ref1"></a></sup>. The following is a simplified model version, which is useful for explanatory purposes:</p><p><em>p(infect|contact) ≈ Θ × sh × ci × in × τ.</em></p><p>Here, the &quot;shedding rate&quot;, <em>sh</em>, is the viral load that the infected person produces through exhalation; this is dependent on what stage of the disease the person is in and whether they are wearing a mask. Conversely, the &quot;intake rate&quot;, <em>in</em>, is how much viral load a susceptible agent breathes in, which is also dependent on mask-usage. Age-dependent susceptibility and infectivity, which were defined in the episim-config, also play a role in the shedding and intake rates. The &quot;contact intensity&quot;, <em>ci</em>, describes the aerodynamic characteristics of the room, which impact the viral load, including size of the room and how much air exchange takes place (i.e. through the opening of windows). Finally, the duration of contact <em>τ</em> is an important factor, which can be gleaned from the activity trajectories. The calibration factor, <em>Θ</em>, is determined through model calibration; this also absorbs all units of the individual factors. All of this together predicts whether susceptible individuals become infected with SARS-CoV-2 during an interaction with an infectious person. For additional details, see (<a href="https://doi.org/10.48550/arXiv.2011.11453" target="_blank" rel="noopener noreferrer">Müller 2020</a>).</p><h2 id="disease-progression-model" tabindex="-1"><a class="header-anchor" href="#disease-progression-model"><span>Disease Progression Model</span></a></h2><p>After an agent is infected with SARS-CoV-2, the disease progression model is used to determine if COVID-19 develops and if (and when) certain disease stages occur. When the infection model reports that a <code>susceptible</code> person is infected, the agent is initially assigned the state of <code>infectedButNotContagious</code>. At the beginning of each iteration (simulated day), there will be a certain chance for the infection state of the agent to change. The worst possible progression would be as follows: <code>infectedButNotContagious</code> → <code>infectious</code> → <code>showingSymptoms</code> → <code>seriouslySick</code> → <code>critical</code> → <code>seriouslySick</code> → <code>recovered</code><sup class="footnote-ref"><a href="#footnote2">[2]</a><a class="footnote-anchor" id="footnote-ref2"></a></sup>. However, starting with the <code>infectious</code> state, there is always a chance of becoming <code>recovered</code>.</p><p><img src="/assets/DiseaseProgressionModel-DyKY3MsC.png" alt="Example Image"><em>Visualization of progression model. See also <a href="https://doi.org/10.48550/arXiv.2011.11453" target="_blank" rel="noopener noreferrer">Müller 2020</a></em>.</p><p>The progression model uses age-dependent transition probabilities to determine whether the agent moves to a more dire state or to the <code>recovered</code> state. The progression model also sets the duration of each state based on medians and standard deviations found in the literature. The agent can only infect other agents in the infectious state or within the first few days of the showing symptoms state; in later states, it is assumed that the agent is either isolating at home or in the hospital. Readers who would like more information on the sources of the transition probabilities are encouraged to read Section 2.3 of (<a href="https://doi.org/10.48550/arXiv.2011.11453" target="_blank" rel="noopener noreferrer">Müller 2020</a>).</p><h2 id="vaccination-model" tabindex="-1"><a class="header-anchor" href="#vaccination-model"><span>Vaccination Model</span></a></h2><p>Historical vaccinations, which are administered to a portion of the population at the beginning of each day, are implemented in <code>VaccinationFromData</code>. To accurately represent the vaccination quotas per age group and manufacturer shares in EpiSim, the model adheres to the official German vaccination quotas and manufacturer shares provided by <a href="https://doi.org10.5281/zenodo.12697471" target="_blank" rel="noopener noreferrer">rki</a>; thus ensuring alignment with the actual distribution within the German population. RKI provides the number of vaccinations per date for four age groups (5-11, 12-7, 18-59 and 60+ years old) on the county level and the number of vaccinations per manufacturer (i.e. Comirnaty, Spikevax, Vaxzevria) on the federal state level. In EpiSim, agents are divided into the same age groups. However, only agents who are a) <code>susceptible</code>, b) have not been vaccinated in the previous 90 days, and c) have not been infected during the previous 90 days are eligible for vaccination. For the booster vaccine, agents must additionally have already been vaccinated to be considered eligible, and for the second booster, agents must have already been boostered to be considered eligible. Per age group and per manufacturer, the available doses per manufacturer are then randomly given to the eligible agents. For each agent, the latest vaccination date, the number of vaccinations as well as the vaccination type they received are saved<sup class="footnote-ref"><a href="#footnote3">[3]</a><a class="footnote-anchor" id="footnote-ref3"></a></sup>.</p><h2 id="antibody-model" tabindex="-1"><a class="header-anchor" href="#antibody-model"><span>Antibody Model</span></a></h2><p>Antibody levels of individual agents are implemented in <code>DefaultAntibodyModel</code>. After the first immunization event (either vaccination or infection), an agent&#39;s strain-specific antibody levels are set. A relative antibody level of 0 translates to no protection, while a relative antibody level of 1 translates to 50% protection against infection. However, these antibody levels are dynamic and may, due to waning, decrease over time. An additional immunization event, either via infection or via vaccination, is necessary to boost the agent&#39;s antibody levels again. For a detailed discussion of EpiSim&#39;s antibody model see <a href="http://dx.doi.org/10.1016/j.isci.2023.107554" target="_blank" rel="noopener noreferrer">Müller 2023</a>.</p><hr class="footnotes-sep"><section class="footnotes"><ol class="footnotes-list"><li id="footnote1" class="footnote-item"><p>The equation used in [episim]{acronym-label=&quot;episim&quot; acronym-form=&quot;singular+short&quot;} to calculate the probability of infection along with a detailed explanation can be found in (<a href="https://doi.org/10.48550/arXiv.2011.11453" target="_blank" rel="noopener noreferrer">Müller 2020</a>). <a href="#footnote-ref1" class="footnote-backref">↩︎</a></p></li><li id="footnote2" class="footnote-item"><p>There is no death in Episim. <a href="#footnote-ref2" class="footnote-backref">↩︎</a></p></li><li id="footnote3" class="footnote-item"><p>If current vaccination data is unavailable or if future developers/users decide not to follow the vaccination quotas provided by RKI, alternative vaccination strategies may be implemented. <a href="#footnote-ref3" class="footnote-backref">↩︎</a></p></li></ol></section></div><!--[--><!--]--></div><footer class="vp-page-meta"><!----><div class="vp-meta-item git-info"><!----><!----></div></footer><nav class="vp-page-nav" aria-label="page navigation"><a class="route-link auto-link prev" href="/docs2/simulationsetup.html" aria-label="EpiSim - Simulation Setup"><!--[--><div class="hint"><span class="arrow left"></span> Prev</div><div class="link"><span class="external-link">EpiSim - Simulation Setup</span></div><!--]--></a><a class="route-link auto-link next" href="/docs2/outputandanalysis.html" aria-label="EpiSim - Outputs and Analysis"><!--[--><div class="hint">Next <span class="arrow right"></span></div><div class="link"><span class="external-link">EpiSim - Outputs and Analysis</span></div><!--]--></a></nav><!--[--><!--]--></main><!--]--></div><!--[--><!----><!--]--><!--]--></div>
    <script type="module" src="/assets/app-BI-xpNOO.js" defer></script>
  </body>
</html>
